- Dendritic Cell-Based Cancer Immunotherapy against Multiple Myeloma: From Bench to Clinic
-
Hoang MD, Jung SH, Lee HJ, Lee YK, Nguyen-Pham TN, Choi NR, Vo MC, Lee SS, Ahn JS, Yang DH, Kim YK, Kim HJ, Lee JJ
- KMID: 2172141
- Chonnam Med J.
- 2015 Apr;51(1):1-7.
- doi: 10.4068/cmj.2015.51.1.1
Although the introduction of stem cell transplantation and novel agents has improved survival, multiple myeloma (MM) is still difficult to cure. Alternative approaches are clearly needed to prolong the survival... -
- CITED
-
- Close
- SHARE
-
- Close
- Sarcoplasmic reticulum Ca²⺠ATPase 2 (SERCA2) reduces the migratory capacity of CCL21-treated monocyte-derived dendritic cells
-
Hong CY, Lee HJ, Choi NR, Jung SH, Vo MC, Hoang MD, Kim HJ, Lee JJ
- KMID: 2361540
- Exp Mol Med.
- 2016 Aug;48(8):e253.
- doi: 10.1038/emm.2016.69
The migration of dendritic cells (DCs) to secondary lymphoid organs depends on chemoattraction through the interaction of the chemokine receptors with chemokines. However, the mechanism of how lymphoid chemokines attract... -
- CITED
-
- Close
- SHARE
-
- Close
